Optometry

NVISION Continues Expansion in Texas with Parkhurst NuVision Joint Venture

Retrieved on: 
Thursday, January 18, 2024

NVISION Eye Centers, a national leader in eye care services, is proud to announce its continued expansion in Texas with a new Joint Venture partnership with Parkhurst NuVision in San Antonio and New Braunfels.

Key Points: 
  • NVISION Eye Centers, a national leader in eye care services, is proud to announce its continued expansion in Texas with a new Joint Venture partnership with Parkhurst NuVision in San Antonio and New Braunfels.
  • Parkhurst NuVision (PNV) was founded in 2013 by Dr. Gregory Parkhurst.
  • NVision’s unique Joint Venture model is very different from private equity funds because at its core lies physician leadership along with substantial equity and influence.
  • “We are thrilled to partner with Dr. Parkhurst and the Parkhurst NuVision team,” said Chris Karkenny, CEO of NVISION.

Hoot Unveils Referral Marketing Automation for Optometrists Focused on Pediatrician Collaboration

Retrieved on: 
Thursday, January 25, 2024

PRINCETON, N.J., Jan. 25, 2024 /PRNewswire/ -- Hoot Health, Inc. a cutting-edge doctor CRM and marketing automation solution proudly unveils Hoot Referrals aimed at assisting optometrists specializing in myopia to increase referrals from pediatricians.

Key Points: 
  • PRINCETON, N.J., Jan. 25, 2024 /PRNewswire/ -- Hoot Health, Inc. a cutting-edge doctor CRM and marketing automation solution proudly unveils Hoot Referrals aimed at assisting optometrists specializing in myopia to increase referrals from pediatricians.
  • Doctor brochures, flyers and cards left at the front desk are outdated in a mobile, video hungry world.
  • Geofencing technology allows optometrists to focus on pediatricians in proximity to their practice, delivering targeted communications that highlight the importance of myopia awareness.
  • Hoot will unveil the Hoot Referrals Automation program to Optometrists at its premier virtual Myopia Management learning event namely, Hootopia on January 27, 2024 at 11am EST - 1pm EST.

BroadcastMed Launches New Platform for Vision Portfolio of Products

Retrieved on: 
Tuesday, January 23, 2024

PentaVision, powered by BroadcastMed, released a new digital platform designed to elevate the user experience for healthcare and optical professionals.

Key Points: 
  • PentaVision, powered by BroadcastMed, released a new digital platform designed to elevate the user experience for healthcare and optical professionals.
  • Driven by many of the industry's leading Optometry and Ophthalmology publications, the platform leverages an intricate network that spans across their entire suite of Vision brands.
  • With a user-centric design, the platform enables HCPs to navigate effortlessly, thereby saving time and enhancing efficiency in accessing the most pertinent and valuable content.
  • BroadcastMed, together with 424 Capital, a growth capital partner, acquired PentaVision in August of 2022 to expand its healthcare audience and secure high-quality content across 11 brands in vision care.

Leading with Clarity: BOSA Equips Eye Doctors for Booming Dry Eye Market

Retrieved on: 
Tuesday, January 16, 2024

NILES, Ill., Jan. 16, 2024 /PRNewswire-PRWeb/ -- M&S Technologies, a leader in computerized vision testing in collaboration with Bruder Healthcare, renowned for dry eye solutions announce the launch of the M&S Bruder Ocular Surface Analyzer (BOSA). The all-in-one innovative device represents an advancement in dry eye assessment and is poised to be a necessity for eye care practices treating ocular surface disease (OSD), including dry eye syndrome. In only 15 seconds per eye, BOSA captures and provides OSD test results. "With the system's unmatched speed, accuracy, and ease of use, doctors can manage dry eye patients more efficiently and effectively, improving outcomes through better data and boosting revenues through time savings," explains Brent Jones of Hilco Vision, parent company of M&S Technologies and Bruder Healthcare.

Key Points: 
  • The all-in-one innovative device represents an advancement in dry eye assessment and is poised to be a necessity for eye care practices treating ocular surface disease (OSD), including dry eye syndrome.
  • "The Bruder Ocular Surface Analyzer is the most comprehensive "one-stop" instrument available to document Dry Eye Disease."
  • BOSA consolidates these diverse tests into one efficient device, offering eye doctors a comprehensive solution within their exam rooms.
  • It is the answer for both the established Dry Eye practice looking to improve efficiency and the eye care practice looking to start a Dry Eye clinic," said Darrell White, MD of SkyVision Centers.

Glaucoma Innovations to be Presented at 13th Annual New Horizons Forum in San Francisco

Retrieved on: 
Tuesday, January 16, 2024

SAN FRANCISCO, Jan. 16, 2024 /PRNewswire/ -- Glaucoma Research Foundation (GRF) will host the 13th Annual Glaucoma 360 New Horizons Forum on February 9th at San Francisco's historic Westin St. Francis Hotel.

Key Points: 
  • SAN FRANCISCO, Jan. 16, 2024 /PRNewswire/ -- Glaucoma Research Foundation (GRF) will host the 13th Annual Glaucoma 360 New Horizons Forum on February 9th at San Francisco's historic Westin St. Francis Hotel.
  • Dr. Ianchulev's keynote lecture "The Innovation Journey of an iDoctor" will shed light on recent and on-the-horizon advances in glaucoma care.
  • The complete program agenda can be viewed on the New Horizons Forum website .
  • New Horizons Forum is the centerpiece of Glaucoma 360 , GRF's signature three-day series of events planned for February 8 to 10, 2024.

TVM Capital Healthcare invests in Vietnamese Eye Care Business Alina Vision in a Growth-Buy Out Transaction

Retrieved on: 
Tuesday, January 16, 2024

SINGAPORE and HANOI, Vietnam, Jan. 16, 2024 /PRNewswire/ -- The Fred Hollows Foundation, Australia, Rohto Pharmaceutical, Japan, and TVM Capital Healthcare, Singapore and Dubai, today announced the closing of a significant equity investment in Alina Vision, a leading eye care business which currently operates two hospitals in Vietnam. 

Key Points: 
  • Alina Vision completed over 2,800 cataract surgeries in 2023 and has a vision to grow its network to a chain of hospitals across Vietnam with significantly increased capacity.
  • The investment of industry specialist growth capital investor TVM Capital Healthcare will provide Alina Vision access to operational, clinical, training, and management resources, in addition to the equity investment, and accelerate the growth plans while elevating quality of care.
  • Hoda Abou-Jamra, Managing Director of TVM Capital Healthcare in Southeast Asia, commented: "This deal marks the most substantial investment by TVM Capital Healthcare in the region to date.
  • Alina Vision already invests significant resources in recruiting and training Ophthalmologists, Optometrists and Nurses with our and Rohto's help.

Cross Keys Capital Advises Bucks-Mont Eye Associates, P.C., in its Partnership with Vision Innovation Partners

Retrieved on: 
Tuesday, January 9, 2024

(BMEA), located in Sellersville, Pennsylvania, in its partnership with Vision Innovation Partners (VIP), a portfolio company of Gryphon Investors.

Key Points: 
  • (BMEA), located in Sellersville, Pennsylvania, in its partnership with Vision Innovation Partners (VIP), a portfolio company of Gryphon Investors.
  • BMEA is a premier provider of ophthalmologic, optometric, and retinal care in Bucks and Montgomery counties in Pennsylvania.
  • "We are delighted to welcome Bucks-Mont Eye Associates as they join the VIP Team," stated Chris Moore, CEO of Vision Innovation Partners.
  • "The Bucks-Mont Eye Associates team is fully aligned with our mission to protect and restore vision for patients in communities we serve.

OCUTRX Debuts Latest AR/XR Vision Headset at CES 2024: Revealing Expanded Uses, Surging Global Interest, and New Pre-Order Opportunities

Retrieved on: 
Tuesday, January 9, 2024

Ocutrx's OcuLenz, an innovative AR/XR headset, is engineered to address advanced macular degeneration (AMD), the leading cause of vision loss among adults over 65 .

Key Points: 
  • Ocutrx's OcuLenz, an innovative AR/XR headset, is engineered to address advanced macular degeneration (AMD), the leading cause of vision loss among adults over 65 .
  • Using advanced pixel manipulation, it overlays high-contrast images onto the user's field of view, compensating for AMD's central vision loss by shifting images to the peripheral vision.
  • Ocutrx invites attendees of the CES ShowStoppers event tonight to visit their booth for an exclusive live demonstration of the OcuLenz headset.
  • Additionally, to access our comprehensive press kit, which includes further insights and visuals on the OcuLenz headset, see our dedicated press kit .

AtriCure Appoints Shlomi Nachman to the Board of Directors

Retrieved on: 
Thursday, January 4, 2024

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced it appointed Shlomi Nachman to its Board of Directors.

Key Points: 
  • AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced it appointed Shlomi Nachman to its Board of Directors.
  • Prior to that, Mr. Nachman served in various roles with increased scope and responsibilities, including Worldwide President of Biosense Webster and Cordis.
  • “I am thrilled to be joining the AtriCure Board during this exciting time of accelerating growth and profitability,” said Mr. Nachman.
  • I have done extensive diligence on the company’s business, prospects, and end user markets, and believe them to be significantly underpenetrated.

AI innovations impress Hong Kong International Optometric Symposium audience

Retrieved on: 
Tuesday, November 14, 2023

At the 21st Hong Kong International Optometric Symposium this year, professionals from Mainland China, the United States, Australia, the United Kingdom and Hong Kong, discussed AI and tele-optometry developments.

Key Points: 
  • At the 21st Hong Kong International Optometric Symposium this year, professionals from Mainland China, the United States, Australia, the United Kingdom and Hong Kong, discussed AI and tele-optometry developments.
  • Discussing whether AI vision test failure may pose a liability risk for optometrists, Prof Mingguang He of The Hong Kong Polytechnic University noted that some insurance companies in the United States and Australia had already included coverage for AI errors.
  • Another example of AI use came from Professor Benny Chung-ying Zee of The Chinese University of Hong Kong Jockey Club School of Public Health and Primary Care.
  • Hong Kong International Optical Fair: https://www.hktdc.com/event/hkopticalfair/en
    Please contact the HKTDC's Communication and Public Affairs Department:
    To view press releases in Chinese, please visit http://mediaroom.hktdc.com/tc